abstract |
The present invention provides novel pradienolactone pyridine compounds, pharmaceutical compositions containing such compounds, and methods of using said compounds as therapeutic agents. These compounds are useful in the treatment of cancers, especially cancers for which drugs targeting the spliceosome and mutations therein are known to be useful. |